To model or not to model: lessons from two vaccinations.
Livio
L
Garattini
Anna
A
Padula
D016265:Conflict of Interest; D004345:Drug Industry; D005060:Europe; D006801:Humans; D007252:Influenza Vaccines / Q000191:economics*; D018803:Models, Economic; D053918:Papillomavirus Vaccines / Q000191:economics*; D011634:Public Health
D007252:Influenza Vaccines; D053918:Papillomavirus Vaccines
Int J Technol Assess Health Care. 2010 Jul;26(3):330-3
20584363
Pharmacoeconomics. 2009;27(6):439-50
19640008
Value Health. 2000 Jul-Aug;3(4):270-6
16464191
Health Policy. 2011 Sep;102(1):89-95
21093952
Intern Emerg Med. 2011 Apr;6(2):163-74
21312004
Pharmacoeconomics. 2009;27(2):127-47
19254046
Eur J Health Econ. 2008 Nov;9(4):311-2
18543010
Am J Epidemiol. 2008 Jul 15;168(2):123-37
18483125
Pharmacoeconomics. 1998 Apr;13(4):397-409
10178664
Pharmacoeconomics. 2010;28(8):609-13
20513161
Prev Med. 2009 May;48(5):444-8
19232368